Key Highlights
- NBIS shares climbed approximately 8.95% during trading, reaching a 52-week peak of $179.96
- The company announced plans to purchase Eigen AI for approximately $643 million to enhance its Token Factory AI infrastructure
- Meta’s $27 billion AI partnership elevated the company’s total contracted backlog close to $50 billion
- Goldman Sachs upgraded its price outlook after the Meta announcement; analyst consensus stands at “Moderate Buy” with an average $154.75 target
- First quarter fiscal 2026 results are scheduled for May 13, with focus on ARR metrics and Eigen integration updates
Shares of Nebius Group (NBIS) began Wednesday’s session at $175.92, climbing to a 52-week peak of $179.96, representing approximately 9% intraday growth. Since January, the equity has surged more than 110%.
Two significant announcements drove this momentum — the company’s $643 million agreement to purchase Eigen AI alongside a $27 billion partnership with Meta.
The Eigen AI transaction brings advanced model-optimization and inference technology to Nebius’s Token Factory ecosystem. Industry analysts believe this acquisition could enhance profit margins while positioning the firm to capture additional production AI workload opportunities.
The Meta partnership represents the larger catalyst. This agreement, combined with current contracts including Microsoft and additional partners, has elevated the company’s total contracted backlog toward the $50 billion threshold. Such figures typically attract substantial Wall Street interest.
Goldman Sachs promptly adjusted its NBIS price outlook upward following the Meta announcement. BWS Financial and DA Davidson both maintain $200 targets with Buy recommendations. Cantor Fitzgerald launched coverage with an Overweight stance, setting a more measured $129 objective. Overall analyst sentiment registers as “Moderate Buy” with a $154.75 average target.
Institutional capital has been flowing into the stock. Millennium Management established a fresh position valued at roughly $11.6 million during Q1. UBS added approximately $9 million to its holdings. Oppenheimer expanded its stake by 90.9% in Q4. Institutional ownership currently represents around 21.9% of shares outstanding.
Understanding the Backlog Narrative
The approximately $50 billion in contracted backlog forms the foundation of the bullish investment thesis. Long-term agreements with hyperscale cloud providers including Meta and Microsoft provide revenue predictability extending into 2026, where management has projected $3.0–$3.4 billion in revenue.
This level of forward revenue certainty remains uncommon in the sector, explaining why growth-focused investors have driven shares to record levels.
Potential Headwinds to Monitor
Several concerns deserve attention. Operating cash flow for fiscal year 2025 totaled roughly $402 million — however, this figure incorporated nearly $983 million in customer advance payments. Removing these advances presents a weaker underlying cash position.
Executives have disclosed that contracted cash inflows will satisfy only approximately 60% of 2026 capital expenditure needs. This funding shortfall presents legitimate questions regarding potential shareholder dilution or additional financing requirements.
Insider transaction activity has been notable. CTO Danila Shtan divested over 13,000 shares in late March. Insider Andrey Korolenko sold more than 31,000 shares during early April. Collectively, company insiders have sold around 135,622 shares valued at over $15.6 million across the past three months.
The equity also displays a beta coefficient of 4.03 — indicating significant volatility in both upward and downward movements. With projected full-year EPS of -$2.44 and a PE ratio of -120.49, the valuation rests entirely on future growth expectations.
First quarter fiscal 2026 financial results arrive May 13. Market participants will focus on annual recurring revenue trends, hyperscaler deployment progress, and initial updates regarding the Eigen AI integration roadmap.
